News
Is the Options Market Predicting a Spike in Akebia Therapeutics Stock?
Investors in Akebia Therapeutics, Inc. AKBA need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2026 $0.50 Call had some of the highest
Buy 3 Stocks With Upgraded Broker Ratings as Geopolitical Woes Linger
This year started on a subdued note. U.S. markets have seen bouts of selling tied to shifting AI expectations and geopolitical tensions, especially Middle East risks and oil-shock fears, prompting
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
Fast-paced Momentum Stock Jabil (JBL) Is Still Trading at a Bargain
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Ciena Surges 73% in 3 Months: Should Investors Still Buy the Stock?
Ciena Corporation CIEN stock has surged 72.7% in the past three months, outperforming the Zacks Communication - Components industry’s growth of 53.3%. The S&P 500 composite and Zacks Computer &
What's Behind Ford's Approval of a New Share Repurchase Plan?
Ford Motor Company F has approved a plan to repurchase up to 31.7 million shares of its stock, a relatively modest buyback to counteract dilution from employee compensation and other convertible
Will Anktiva Continue to Drive ImmunityBio's Top-Line Growth in 2026?
ImmunityBio IBRX had an encouraging year in 2025. Last month, the company reported its fourth-quarter and full-year 2025 results, which beat both our earnings and sales estimates — all thanks to the
Software Stocks Are Down—Expert Says These 3 Names Still Look Strong
Software stocks have been under pressure, but not every company in the sector deserves to be sold off with the group. In a recent conversation with Kuran Francis of FinTek, the discussion focused
Lucid's Investor Day Signals Big Ambitions: Buy LCID Stock Now?
At its investor day last week, Lucid Group LCID outlined how it plans to evolve from a niche luxury EV maker to a scaled, technology-driven mobility platform. The company detailed its upcoming
X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates
X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $6.01 per share a year ago. These
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates
Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to earnings of $0.23 per share a year ago
CVNA Stock Before 5-for-1 Split: Do Fundamentals Justify a Buy Now?
Used vehicle e-retailer Carvana CVNA recently approved a 5-for-1 forward stock split, its first-ever stock split. Effective May 7, the shares will begin trading on a split-adjusted basis.
Stock
2 Stocks With Governmental Tailwinds to Drive Them Higher
A little government exposure can go a long way for a business, especially those still in their early phases. Government spending, specifically defense, accounts for approximately 3% of GDP, making
GDS Holdings (GDS) Beats Q4 Earnings and Revenue Estimates
GDS Holdings (GDS) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.1 per share a year ago. These
Kinross Gold Delivers Record Q4 Margins: Can it Sustain the Momentum?
Kinross Gold Corporation KGC logged a record fourth-quarter operating margin, courtesy of a rally in gold prices, cost management and strong production performance. Its margin per gold equivalent
FEAM Strengthens Position With High-Margin Boron Innovation
5E Advanced Materials, Inc. FEAM recently reported a key R&D milestone with the production of a proprietary meta boric acid product featuring 80% B2O3 content, higher than conventional boric acid
Quaker Chemical and EV Fluids: Why APAC Wins Matter in 2026
Quaker Chemical Corporation KWR is showing pockets of growth, even as many end markets stay muted. The company’s outgrowth is being shaped by sustained share gains and electric vehicle (EV)-related
KWR Stock: Undervalued Play or Execution Risk Waiting to Unfold?
Quaker Chemical Corporation KWR is in a tug-of-war between improving fundamentals and a stock that has lagged meaningfully. Investors are weighing a discounted valuation against near-term friction
Can Execution Power Quaker Chemical's Growth in a Soft Market?
Quaker Chemical Corporation KWR is heading into 2026 with muted end-market expectations, but management still sees a path to steady growth. The investment debate centers on whether the company can
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The best way to
3 Top-Ranked Mutual Funds for Your Retirement
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The easiest, most reliable way
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The easiest way to judge a
Best-Performing Leveraged ETFs of Last Week
Last week was marked by the Iran war–driven market volatility. The S&P 500 lost about 1%, the Dow Jones Industrial Average fell 1%, the Nasdaq Composite declined 0.4%, and the Russell 2000 slipped



